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The Mycobacterium tuberculosis (Mtb) gene product encoded
by open reading frame Rv1657 is an arginine repressor
(ArgR). All genes involved in the l-arginine (hereafter
arginine) biosynthetic pathway are essential for optimal
growth of the Mtb pathogen, thus making MtbArgR a
potential target for drug design. The C-terminal domains of
arginine repressors (CArgR) participate in oligomerization
and arginine binding. Several crystal forms of CArgR from
Mtb (MtbCArgR) have been obtained. The X-ray crystal
structures of MtbCArgR were determined at 1.85 A ˚ resolution
with bound arginine and at 2.15 A ˚ resolution in the
unliganded form. These structures show that six molecules
of MtbCArgR are arranged into a hexamer having approx-
imate 32 point symmetry that is formed from two trimers. The
trimers rotate relative to each other by about 11  upon binding
arginine. All residues in MtbCArgR deemed to be important
for hexamer formation and for arginine binding have been
identiﬁed from the experimentally determined structures
presented. The hexamer contains six regular sites in which
the arginine molecules have one common binding mode and
three sites in which the arginine molecules have two
overlapping binding modes. The latter sites only bind the
ligand at high (200 mM) arginine concentrations.
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1. Introduction
More than 1.7 billion individuals worldwide are infected with
the Mycobacterium tuberculosis (Mtb) pathogen (Raviglione,
2003) and approximately two million lives are lost to TB
annually (http://www.who.int/mediacentre/factsheets/fs104/en/).
TB is becoming more difﬁcult to combat owing to the
appearance of drug-resistant strains (Coker, 2004). In order to
understand the physiology of this bacillus on a molecular
level, the M. tuberculosis Structural Genomics Consortium
(TBSGC) was founded with the goal of determining the three-
dimensional structures and functions of the proteins from the
TB genome (Terwilliger et al., 2003). Our laboratory has
adopted the strategy of targeting the proteins from several
Mtb metabolic pathways, in particular the proteins involved in
arginine biosynthesis. Recently, the structures of the enzymes
encoded by open reading frames Rv1652 (ArgC) and Rv1656
(ArgF) that are involved in this pathway have been deter-
mined (Cherney et al., 2007; Sankaranarayanan et al., 2008).
Rv1657 has been annotated as encoding an arginine repressor
(ArgR) that regulates the transcription of genes of the
arginine-biosynthetic pathway. The ArgR monomer is
composed of two domains: the N-terminal domain is respon-
sible for DNA binding and the C-terminal or core domain isresponsible for oligomerization and arginine binding (Tian &
Maas, 1994). In the presence of elevated arginine concentra-
tions, ArgR binds to DNA operators within the promoter
regions of the arginine-biosynthetic and catabolism genes
(Larsen et al., 2005; Caldara et al., 2006), thereby shutting
down arginine metabolism. All of the genes involved in the
arginine-biosynthetic pathway are essential for optimal
growth of the Mtb pathogen (Sassetti et al., 2003), thus making
MtbArgR a potential target for antibiotic drug design.
To date, full structures of the apo arginine repressor from
Bacillus stearothermophilus (Bst) and the apo arginine
repressor/activator (AhrC) from B. subtilis (Bs) have been
reported (Ni et al., 1999; Dennis et al., 2002). Structures have
also been determined of isolated C-terminal and N-terminal
domains of apo ArgR from Escherichia coli (Ec; Van Duyne et
al., 1996; Sunnerhagen et al., 1997) and of isolated N-terminal
domains of BsAhrC that are not bound to DNA (Garnett et
al., 2007a) and of the same domains bound to an 18 bp DNA-
operator site (Garnett et al., 2008). In the case of arginine-
bound proteins, only the structures of their C-terminal
domains (EcCArgR, BstCArgR and BsCAhrC) have been
determined (Van Duyne et al., 1996; Ni et al., 1999; Garnett et
al., 2007b). It was found that these proteins consist of six
monomers and form a dimer of trimers with approximate 32
symmetry. The C-terminal domains of the monomers make up
a compact core of the hexamers (the core hexamer). The
N-terminal domains lie around the core hexamer in loosely
associated pairs. The trimers rotate about each other upon
arginine binding, which presumably
allows the correct matching between the
N-terminal domains and the DNA
operators. The arginine complexes of
EcCArgR, BstCArgR and BsCAhrC
have six ligand molecules bound to the
core hexamer.
Here, we report several crystal
structures of MtbCArgR in the apo
form as well as with six and nine argi-
nine molecules bound to the core
hexamer. Based on these results, we
have been able to study the arginine-
binding sites in MtbArgR and to
analyze the structural effects resulting
from arginine binding.
2. Materials and methods
2.1. Protein preparation, crystallization
and data collection
Rv1657 was puriﬁed as a GST-fusion
protein and then cleaved by restricted
proteolysis with TEV proteinase to
produce the targeted protein. However,
the protein was likely to have under-
gone additional cleavage by endo-
genous proteases and the resulting
preparation had one half of the
expected molecular weight, as described
in detail elsewhere (Lu et al., 2007). The
likely cleavage site is the peptide bond
following Arg88 of the linker between
the N- and C-terminal domains. The C-
terminal domain (starting approxi-
mately at residues 89–92 and ending at
residue 170) had crystallized. Three
different crystal forms of MtbCArgR
have been grown. Crystallization of the
apo form I (Table 1) from 20% PEG
10 000, 0.1 M HEPES buffer pH 7.5 has
been described previously (Lu et al.,
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Table 1
Data-collection and reﬁnement statistics.
Values in parentheses are for the high-resolution shell.
Crystal I II III
Ligands per hexamer 0 6 9
PDB code 3bue 2zfz 3cag
Space group P1 P212121 P212121
Unit-cell parameters
a (A ˚ ) 53.22 57.67 57.76
b (A ˚ ) 57.24 75.95 75.65
c (A ˚ ) 57.33 107.10 108.02
  ( ) 66.2 90.0 90.0
  ( ) 62.2 90.0 90.0
  ( ) 82.0 90.0 90.0
Z 62 4 2 4
Solvent content (%) 57.8 49.2 49.5
Data collection
Temperature (K) 100 100 100
Detector ADSC Q315 MAR Mosaic 325 MAR Mosaic 325
Wavelength (A ˚ ) 0.97848 0.97947 1.10552
Resolution (A ˚ ) 50.00–2.15 (2.23–2.15) 50.00–1.85 (1.92–1.85) 50.00–1.90 (1.97–1.90)
No. of unique reﬂections 28194 (2498) 41086 (4025) 36125 (3141)
Multiplicity 1.8 (1.7) 4.8 (4.5) 6.9 (6.8)
I/ (I) 11.8 (2.3) 17.8 (2.0) 15.7 (4.2)
Completeness (%) 99.8 (99.7) 99.8 (99.2) 95.6 (84.6)
Rmerge† 0.061 (0.252) 0.094 (0.800) 0.132 (0.422)
Reﬁnement
Reﬁnement resolution 50.0–2.15 50.0–1.85 50.0–1.90
Rworking/Rfree‡ 0.17/0.23 0.18/0.23 0.17/0.22
No. of atoms
Protein 3400 3402 3466
Water 361 407 357
l-Arginine in regular sites — 72 72
l-Arginine in additional sites — — 36
Guanidine — 8 —
Average B factors (A ˚ 2)
Protein 24.6 21.0 22.25
Water 35.5 33.5 35.6
l-Arginine in regular sites 13.8 15.6
l-Arginine in additional sites — — 36.9
Guanidine — 31.3 —
R.m.s. deviations from ideality
Bond lengths (A ˚ ) 0.020 0.015 0.015
Bond angles ( ) 1.82 1.57 1.48
Ramachandran plot
Highly favored (%) 94.6 93.3 94.8
Allowed (%) 5.1 6.7 5.2
Generously allowed (%) 0.3 0.0 0.0
Disallowed (%) 0.0 0.0 0.0
† Rmerge =
P
hkl
P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the ith intensity measurement and hI(hkl)i is the
mean of all measurements of I(hkl). ‡ Rworking and Rfree =
P
hkl½jFoðhklÞj   jFcðhklÞj =
P
hkl jFoðhklÞj for reﬂections in
the working and test sets. Rfree was calculated using 5% of data.2007). This form belonged to the triclinic space group P1 with
six protein subunits in the unit cell (a crystallographic
hexamer). Arginine-bound forms were grown under the
following crystallization conditions. Equal volumes (1–2 ml) of
protein solution (at 10 mg ml
 1 in 5 mM Tris–HCl pH 7.4 and
100 mM NaCl) and the crystallization buffer were combined
and equilibrated against 1 ml crystallization buffer by vapor
diffusion in hanging drops. Crystal form II (Table 1) resulted
from 20% PEG 10 000, 0.1 M Tris–HCl pH 8.5, 0.1 M guani-
dine–HCl and 5 mM arginine. Crystal form III (Table 1) grew
from slightly different conditions: 12% PEG 10 000, 0.1 M
HEPES buffer pH 7.0, 10% glycerol and 0.2 M arginine. Forms
II and III of arginine-bound MtbCArgR belonged to the
orthorhombic space group P212121 with a hexamer in the
asymmetric unit. The crystals chosen for data collection were
rinsed in a cryoprotectant containing 30% glycerol in mother
liquor and ﬂash-cooled in liquid nitrogen. Data sets were
collected either on beamline 7-1 at the Stanford Synchrotron
Radiation Laboratory (SSRL) or on beamline 8.3.1 at the
Advanced Light Source (ALS) at the Lawrence Berkeley
National Laboratory (Table 1). Raw intensity data were
reduced, merged and scaled using the HKL-2000 suite
(Otwinowski & Minor, 1997).
2.2. Structure determination, refinement and analysis
Structure solution and reﬁnement were carried out using
programs from the CCP4 suite (Collaborative Computational
Project, Number 4, 1994). The crystal structure of MtbCArgR
was initially solved in the orthorhombic crystal form II by
molecular replacement using MOLREP (Vagin & Teplyakov,
1997). An alanine model was constructed from the trimer of
C-terminal domains of BstArgR (PDB code 1b4b; 39%
identity) in which all non-identical residues were replaced by
alanine residues while identical residues were not changed.
This trimer was used as the search model for molecular
replacement using data in the resolution range 20–4 A ˚ . Once
the correct solution had been achieved, further building of the
polypeptide chains was accomplished using ARP/wARP
(Perrakis et al., 1999); structure solutions for the other crystal
forms were carried out using MOLREP. Manual ﬁtting of side
chains was performed using XtalView/Xﬁt (McRee, 1999) and
the structures were all reﬁned using REFMAC 5.0
(Murshudov et al., 1997). The ﬁnal structures were evaluated
using PROCHECK (Laskowski et al., 1993). Table 1
summarizes the crystal parameters, data-collection and
processing and reﬁnement statistics. The programs ClustalW
(Thompson et al., 1994) and ALIGN (Cohen, 1997) were used
for sequence alignments and structural comparisons, respec-
tively. Quaternary structure analyses were carried out with the
EMBL–EBI PISA server (Krissinel & Henrick, 2005, 2007).
Figures were generated using PyMOL (DeLano, 2002).
3. Results and discussion
3.1. Overall structure
Well deﬁned electron densities were observed for all
hexamer subunits in both the triclinic and orthorhombic
crystal forms. The overall structures of the holo MtbCArgR
hexamer and the superposed apo MtbCArgR hexamer are
shown in Fig. 1(a). Both hexamers are made up of two trimers
and exhibit noncrystallographic 32 symmetry. The bottom
trimers were used to perform the superposition while the top
trimers retained their relative positions. Overall, the structures
of all the trimers are very similar, with a maximum r.m.s.d. of
0.61 A ˚ for 900 main-chain atom pairs between trimers from
the arginine-free and arginine-bound hexamers. In the argi-
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Figure 1
Overall structure of MtbCArgR. All subunits are shown as ribbon drawings and colored separately. (a) Superposition of apo (darker shade) and holo
(lighter shade) hexamers viewed along a dyad symmetry axis. Only subunits D, E and F were used for structural alignment. The holo hexamer has six
arginine molecules bound (two of them in this view are labeled RA and RD); these molecules are depicted by sticks with the C atoms in the color of the
nearest subunit and with N and O atoms in blue and red, respectively. (b) Superposition as in (a) except viewed along the threefold symmetry axis from
the top trimers with the bottom trimers removed for clarity. (c) The subunit of MtbCArgR has  /  topology (       ).nine-free hexamer each subunit from the top trimer is located
directly above the adjacent subunit from the bottom trimer.
However, in the arginine-bound hexamer the top trimer is
rotated with respect to the bottom trimer by 11  about the
threefold axis relating the subunits in the hexamer (clockwise
when viewed from the top) compared with the arginine-free
hexamer (Figs. 1a and 1b). This rotation is less than the
equivalent rotation of 15  observed for other arginine
repressors (Ni et al., 1999; Garnett et al., 2007b).
All subunits within the hexamers have well conserved
structures, with a maximum r.m.s.d. of 0.3 A ˚ for approximately
300 main-chain atom pairs. Each subunit of the C-terminal
domain of the MtbArgR polypeptide chain has an  / 
topology in which the three  -helices alternate with pairs of
strands in a four-stranded  -sheet (       ;F i g .1 c). The
 -sheets from the three different subunits associate around
the threefold axis to form the trimer. On the other hand, only
small regions of helices  1 and  2 are present at the interface
between the trimers in the hexamer. As a result, much weaker
interactions are expected between trimers than between the
individual subunits of each trimer. Indeed, there are 1301 and
1320 A ˚ 2 of solvent-accessible surface area buried in the
interfaces between subunits in the top and bottom apo trimers,
respectively, and 1131 A ˚ 2 in the interface between trimers in
the hexamer. The EMBL–EBI PISA server gives a change in
solvation energy of  45.6 and  46.0 kJ mol
 1 upon formation
of the interfaces between the subunits in the top and bottom
apo trimers, respectively, but only  30.1 kJ mol
 1 upon their
association into a hexamer. There are also signiﬁcantly higher
total numbers of hydrogen bonds (HB) and salt bridges (SB)
at the interfaces between subunits in each
apo trimer (21 HB and ten SB for the top
trimer and 20 HB and 12 SB for the bottom
trimer) than at the interface between
trimers (eight HB and nine SB). Thus, the
MtbCArgR hexamer is more correctly
described as a dimer of trimers than as a
hexamer. We shall discuss the interactions
between subunits in more detail in x3.4.
3.2. Regular arginine-binding sites
There are a total of six clefts located
between the subunits in the top and bottom
trimers; these clefts extend roughly parallel
to the threefold axis of the dimer of trimers
(Fig. 1a). Well deﬁned electron density for
the arginine ligands is observed in all the
clefts. Arginine molecules lying in two
adjacent clefts on the top and bottom
trimers have their side chains facing each
other according to the 32 symmetry of the
hexamer. It is worth noting that each argi-
nine-binding site binds the ligand molecule
in a unique conformation. Such a binding
mode is similar to the pattern observed in
the known structures of other arginine
repressors (Van Duyne et al., 1996; Ni et al.,
1999; Garnett et al., 2007b); we will refer to
these binding sites as the ‘regular’ binding
sites. In this way, at moderate arginine
concentrations the MtbCArgR hexamer
binds up to six arginine molecules, one in
each binding cleft.
Fig. 2(a) shows the well ordered binding
site for arginine molecule RA located in the
cleft between subunits A and C (the other
regular binding sites look similar). All ligand
atoms ﬁt well in the OMIT electron-density
map at the 3.0  contour level (Fig. 2a), in
agreement with the low values of their
atomic B factors. The  -carboxyl O atoms of
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Figure 2
(a) The regular binding site is located in the cleft between subunits A and C; ligand molecule
RA is bound to this site. Also shown is the ligand molecule RD bound in the adjacent cleft. The
OMIT |Fo|   |Fc| electron-density map for RA and RD is contoured at the 3.0  level with the
ﬁnal reﬁned models of RA and RD superposed. Binding residues are represented by sticks with
C atoms in the color of the subunit to which the residue belongs. Hydrogen bonds are drawn as
black broken lines. The two hydrogen bonds involving the  -amino group of the bound
arginine are bifurcated. In their formation, residue Asp132 also plays the role of proton
acceptor for Thr142 as does the water molecule W for Thr148. The guanidinum group of each
ligand forms an ion pair with the  -carboxyl group of aspartic acid residue Asp146 that belongs
to the opposite trimer. (b) Electrostatic surface representation of the two adjacent binding
clefts with arginine ligands RA and RD.( c) Superposition of the arginine-binding sites of
MtbCArgR (green), EcArgR (magenta), BstArgR (yellow) and BsAhrC (orange). Residues
involved in arginine binding are shown as sticks and the MtbArgR numbering is used; also
shown are the two bound arginine molecules RA and RD.molecule RA form three hydrogen bonds to the main-chain N
atoms of residues Asp146 and Asp147 of the C subunit and to
Ala144 of the A subunit (Fig. 2a). The  -amino group of RA
also forms three hydrogen bonds: a hydrogen bond to a side-
chain O atom of Asp132 of the A subunit, a bifurcated
hydrogen bond with the main-chain and side-chain O atoms of
Thr142 of the A subunit and a bifurcated hydrogen bond with
the side-chain O atoms of Asp147 and Thr148 of the C
subunit. The other O atom of the Asp132 side chain and the
water molecule W bound in the cleft (Fig. 2a) accept protons
from the side-chain O atoms of Thr142 and Thr148, allowing
the bifurcated hydrogen bonds to form. Two N atoms N
 1 and
N
 2 of the guanidinium group of the bound arginine make
hydrogen bonds and salt bridges to the side-chain O atoms of
Asp146 of the F subunit. Finally, there is a hydrogen bond
between one of these two arginine N atoms and the unpro-
tonated N
 1 atom of His125 of the A subunit. An electrostatic
surface-potential calculation showed strong negative charge in
the binding clefts. The surface of the two adjacent clefts with
bound arginine ligands RA and RD is presented in Fig. 2(b).
There are also hydrophobic contacts between the ligand
molecule RA and residues Gly145 of the C subunit and
Ala128, Ser129 and Thr142 of the A subunit. However, these
residues do not form a deep binding cavity. Superposition of
the MtbCArgR hexamer structure with the core-hexamer
structures of other arginine repressors (EcArgR, BstArgR and
BsAhrC) shows that their known arginine-binding sites are
similar to the regular binding sites in MtbArgR (Fig. 2c). The
binding residues described above are fully conserved, with the
exceptions of His125 and Ala144, which are substituted by a
glutamine (in EcArgR and BsAhrC) and a cysteine (in
BstArgR and BsAhrC), respectively.
3.3. Additional arginine-binding sites
We have found that the MtbCArgR hexamer can bind three
additional arginine molecules at 200 mM arginine concentra-
tion. Each molecule is distributed between two mutually
exclusive binding modes in the gap between trimers. Fig. 3
shows all nine ligand molecules as viewed along the threefold
axis from the top trimer and Fig. 4(a) demonstrates a closing
of the gap with the additional ligands labeled RAE,R BD and
RCF. These ligand molecules at 50% occupancy for each
binding mode are well deﬁned in the OMIT electron-density
map contoured at the 2.0  level (Fig. 4a). The average B
factors of the atoms of additional arginine molecules are
slightly higher (35–40 A ˚ 2) than those of the atoms of the rest
of the protein molecules and the six regular arginine mole-
cules (Table 1). Figs. 3 and Fig. 4(a) show that binding of three
ligand molecules in the gap between trimers occurs in accor-
dance with the approximate 32 symmetry of the hexamer. In
particular, the three twofold axes relate the positions of the
two possible mutually exclusive modes of the ligand molecules
to each other.
Fig. 4(b) shows the additional binding site for the arginine
molecule RAE stretched between subunits A and E.T h e
binding sites for RBD and RCF look similar. The two
 -carboxyl groups of the neighboring Asp146 residues that
play important roles in binding the regular arginine molecules
are also largely responsible for binding one additional ligand.
The binding is primarily by hydrogen bonding and electro-
static interactions with the guanidinium group of the ligand.
As a result, the rest of the ligand could be placed in one of the
opposite directions with equal probability. There are three
pairs of neighboring  -carboxyl groups of Asp146 in the
hexamer, resulting in the binding of three additional arginine
molecules, each of which is distributed into two possible
binding modes. When the  -amino and  -carboxyl groups of
an additional arginine molecule are positioned close to His125
of one subunit, the guanidinium group of the ligand causes
His125 of the other subunit to move closer to it to form a
hydrogen bond. As a result, the imidazole group of each
His125 adopts two conformations.
The  -amino group of arginine RAE in the position shown in
green (Fig. 4b) forms hydrogen bonds to the main-chain O
atom of Gly145 and to the N
 1 atom of His125 (subunit A). In
order for the latter hydrogen bond to form, the imidazole ring
of His125 must occupy a position away from the arginine. The
 -carboxylate O atom of the bound RAE receives a hydrogen
bond from the main-chain N atom of His125. In addition, the
 -carboxyl group of arginine is located near to the N-terminus
of helix  2 on subunit A. Thus, there is a stabilizing electro-
static interaction from the helix  2 dipole moment and the
negative charge of the  -carboxylate of the bound arginine.
The ligand RAE in this position also interacts with residues
His125 and Asp146 of subunit E. The N atoms N
" and N
 2 of
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Figure 3
The MtbCArgR hexamer is bound with six arginine molecules in the
regular sites; three disordered arginine molecules are bound in the gap
between the trimers. The view is along the threefold-symmetry axis from
the top trimer, perpendicular to the view in Fig. 1(a). The three additional
arginine molecules are labeled RAE,R BD and RCF. Each of them adopts
two binding positions each at half occupancy. The OMIT |Fo|   |Fc|
electron-density map for the additional ligand molecules is contoured at
the 2.0  level with their ﬁnal reﬁned models superposed.the guanidinum group of RAE donate hydrogen bonds (and
ion-pair interactions) to the side-chain O
 2 of Asp146 and to
the N
"2 atom of His125 in the position shown in Fig. 4(b). Thus,
interactions that involve the guanidinum group of the bound
arginine are likely to play the most important role in binding.
The 2|Fo|   |Fc| electron-density map for the guanidinum
group of the additional arginine molecules is better deﬁned
than the regions involving the other atoms of the arginine
molecules. The same interactions discussed above are also
present for the twofold-related RAE molecule (Fig. 4b, cyan)
with subunits E and A, respectively. It is worth noting that the
residues of the additional binding sites in MtbArgR are
conserved in EcArgR, BstArgR and BsAhrC. After super-
position of their structures with the MtbCArgR structure, the
corresponding residues are well aligned.
The binding of three additional arginine
molecules at extreme arginine concentra-
tions shows the capacity of MtbCArgR to
bind arginines. The regular arginines bind in
the clefts between subunits and the addi-
tional arginines bind in the gap between the
trimers. The physiological meaning of this
ﬁnding is not clear.
3.4. Structural effects of arginine binding
The C atoms of residues Leu104, Gly122,
Ala123 and Tyr126 participate in hydro-
phobic contacts at the interface between the
trimers. There are also hydrogen bonds and
ion pairs at this interface, most of which are
relatively weak (Table 2). Rotation of the
trimers with respect to each other upon
arginine binding does not change the resi-
dues that are responsible for the hydro-
phobic contacts between the trimers;
however, it does change the hydrogen bonds
and the ion pairs that occur between them.
In the holo hexamer, six new hydrogen
bonds are formed between the O and N
atoms of residues Gly122 and Tyr126,
respectively (one residue from each subunit
of one trimer and the other residue from the
adjacent subunit of the other trimer). At the
same time, most hydrogen bonds and ion
pairs (between residues Arg99 and Glu103)
present at the interface between the trimers
in the apo hexamer are lost as a result of the
conformational change in the holo hexamer
(Table 2). The trimers can also interact
through hydrogen bonds and salt bridges
involving regular and additional ligand
molecules (Figs. 2a and 4b). The major
conformational change in each subunit upon
binding the three additional argininesoccurs
in the His125 residues: their imidazole rings
adopt two alternative positions in order to
accommodate the additional ligands and make hydrogen-
bonding interactions with them.
Here, we have shown that MtbCArgR forms a dimer of
trimers that is similar to the other known structures of arginine
repressor proteins. Also, the trimers rotate relative to each
other in a similar fashion by 11  upon arginine binding. The
interactions between the guanidinium groups of the bound
arginines with the  -carboxyl groups of Asp146 of the oppo-
site trimer are thought to be the cause of this rotation. The
rotation of the two C-terminal trimers about one another
enables the two neighboring N-terminal domains to rearrange
their positions so that they can properly ﬁt into two major
grooves of the DNA operator and as a result block arginine
biosynthesis (Ni et al., 1999; Garnett et al., 2008).
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Figure 4
(a) A close-up of the gap between the trimers of the MtbCArgR hexamer bound with the three
additional arginine molecules viewed approximately as in Fig. 3. The molecule RCF stretches
between subunits C and F. The molecules RAE and RBD are stretched between subunits A and
E and between subunits B and D, respectively. (b) The binding site for the ligand molecule
RAE. Binding residues are represented by sticks. Residue His125 adopts two positions that
differ in the orientation of the imidazole group. This group must be located far from the ligand
if the latter adopts the position with the  -amino and  -carboxyl groups located near the
corresponding His125. The imidazole group of the His125 in the other subunit can adopt both
positions in this case. Hydrogen bonds are shown as black broken lines. There are also ion pairs
between the ligand guanidinum group and the  -carboxyl groups of the aspartic acid residues
Asp146.It has been shown that l-canavanine, which is an arginine
mimic, can also interact with ArgR; however, it is not an
effective corepressor (Schwartz & Maas, 1960; Van Duyne et
al., 1996). The binding site of l-canavanine on the C-terminal
domain of ArgR is unknown. The oxygen substitution for the
C
  in l-canavanine dramatically decreases the pK of the
guanidinium group from 12 in arginine to 6–7 in l-canavanine.
Finding an arginine-mimicking compound that is a strong
corepressor could produce a new type of drug against TB.
X-ray diffraction data were collected on beamline 8.3.1 of
the Advanced Light Source (ALS) at Lawrence Berkeley
Laboratory under an agreement with the Alberta Synchrotron
Institute (ASI). The ALS is operated by the Department of
Energy and supported by the National Institutes of Health.
Beamline 8.3.1 was funded by the National Science Founda-
tion, the University of California and Henry Wheeler. The
ASI synchrotron-access program is supported by grants from
the Alberta Science and Research Authority (ASRA), the
Alberta Heritage Foundation for Medical Research
(AHFMR) and Western Economic Diversiﬁcation of the
Canadian Government. MNGJ is supported by the Canadian
Institutes of Health Research and the Alberta Heritage
Foundation for Medical Research and is a Canada Institutes of
Health Research (CIHR) Canada Research Chair.
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Table 2
Hydrogen-bonding interactions at the interface between trimers in MtbCArgR hexamers.
Residues in italics also form ion pairs between the guanidinum and carboxyl groups of their side chains.
Apo form (3bue) Distance (A ˚ ) Holo form with six ligands (2zfz) Distance (A ˚ ) Holo form with nine ligands (3cag) Distance (A ˚ )
Subunit A Subunit F Subunit A Subunit F Subunit A Subunit F
Arg99 N
 1 Glu103 O
"1 3.3 Arg99 N
 1 Glu103 O
"1 3.6 Gly122 O Tyr126 N 3.5
Glu103 O
"2 Arg99 N
 2 3.7 Glu103 O
"1 Tyr126 O
  2.5 Tyr126 N Gly122 O 3.5
His125 N
"2 Asp146 O
 1 3.2 Gly122 O Tyr126 N 3.5
Tyr126 N Gly122 O 3.7
Subunit B Subunit E Subunit B Subunit E Subunit B Subunit E
Glu103 O
"1 Arg99 N
 2 3.8 Arg99 N
 1 Glu103 O
"2 3.1 Gly122 O Tyr126 N 3.6
Arg133 N
 2 Pro121 O 3.0 Arg99 N
 2 Glu103 O
"1 3.1 Tyr126 N Gly122 O 3.4
Gly122 O Tyr126 N 3.3
Tyr126 N Gly122 O 3.5
Tyr126 O
  Glu103 O
"1 2.4
Subunit C Subunit D Subunit C Subunit D Subunit C Subunit D
Arg99 N
 1 Glu103 O
"1 3.8 Gly122 O Tyr126 N 3.6 Glu103 O
"2 Arg99 N
 2 3.2
Glu103 O
"2 Arg99 N
 1 3.7 Tyr126 N Gly122 O 3.5 Gly122 O Tyr126 N 3.5
Glu103 O
"2 Arg99 N
 2 3.8 Tyr126 N Gly122 O 3.4